Image-based Remote Monitoring in Cardiac Surgery Patients (FORSEE-3)

April 9, 2025 updated by: Lukas Dekker, Catharina Ziekenhuis Eindhoven

Image-based Remote Monitoring in Cardiac Surgery Patients: FORSEE 3 Trial

In this observational study, 100 patients admitted to the Cardiothoracic ward will be additionally monitored with video-cameras. The video-cameras will measure heart- and respiration rate continuously. Other features, such a cardiac arrhythmias and context analysis may be added as well. Data will be analysed retrospectively and will be compared with vital parameters measured with healthdot- and spot check measurements.

Study Overview

Status

Completed

Detailed Description

Rationale: In hospitals forty percent of unanticipated deaths occur in low-acuity departments. This alarming figure reflects the limited degree to which the cardiorespiratory status of patients is monitored in these departments, due to the obtrusiveness and expense of existing monitoring technologies, as well as the unpractically high clinical workload and costs that deployment of such technologies would entail. We have previously shown that an image-based monitoring technology reliably estimates heart rhythm and breathing rate under controlled conditions.

Objective: This project explores image-based monitoring of the cardiorespiratory status of patients as an innovative unobtrusive method that could eventually aid to reduce workload for the staff and better predict (acute) deterioration or adverse events. The purpose of this study is to evaluate the feasibility, in terms of system fidelity and acceptance, of long-term image-based monitoring in a cardiothoracic ward setting. Secondary objectives are to evaluate the validity of image-based vital signs and circadian rhythms in comparison with reference devices, the discriminative ability of image-based monitoring in the prediction of clinical deterioration and effect of clinical deterioration detected with remote monitoring during hospital admission on long-term patient outcomes.

Study design: Observational study Study population: 100 cardiac surgery patients

Main study parameters/endpoints: Primary endpoints are (1) insight in signal loss due to artifacts and time 'out of scope' of patients, (2) storage and processing solutions to enable conversion of large amounts of image-based data into vital signs and (3) level of acceptance by healthcare staff and patients. Secondary endpoints are performance of image-based vital signs and circadian rhythms in comparison with reference devices and sensitivity and specificity for the prediction of deterioration based on the image-based data. Moreover, potential time gain and predictive value of each image-based parameter will be assessed. Another secondary endpoint is insight in the relation of occurrence of clinical deterioration detected with the image-based monitoring technology during admission and long-term patient outcomes.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Noord-brabant
      • Eindhoven, Noord-brabant, Netherlands, 5623 EJ
        • Catharina Ziekenhuis Eindhoven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The intended population within this study will be cardiac surgery patients, admitted to the cardio-thoracic ward in the Catharina hospital, because they are at risk to develop postoperative complications. The research team will approach eligible patients who are scheduled to undergo cardiac surgery in collaboration with the cardio-thoracic surgeons. On average, 20 cardiac surgeries take place each week.

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Willing and able to sign informed consent form
  • Patients admitted to the cardio-thoracic ward postoperative after cardiac surgery
  • Planned stay on the cardio-thoracic ward at least 48 hours

Exclusion Criteria:

  • Pregnant patients
  • Inability to provide written informed consent
  • Mental disability
  • Language barrier
  • Inability to wear Healthdot: known severe allergy for the tissue adhesive used in the Healthdot, any skin condition or use of topicals at the area of application of the Healthdot

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Postoperative after cardiac surgery
Patients after cardiac surgery will participate in the trial during their postoperative stay on the cardiothoracic ward.
Unobtrusive, vital signs measurements with remote photoplethysmography

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of signal coverage of remote, image-based monitoring in cardiac surgery patients on a general ward
Time Frame: 5-7 days
Percentage of signal loss can be due to artifacts as a result movement, lighting conditions, clinical interventions and time 'out of scope' of patients
5-7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The validity of remote, image-based heart- and respiration rate in comparison with heart- and respiration rate measured with the Healthdot (smart patch)
Time Frame: 5-7 days
Agreement of image-based heart- and respiration rate with healthdot data
5-7 days
The validity of remote, image-based monitoring of circadian rhythms in comparison with the Healthdot (smart patch)
Time Frame: 5-7 days
Agreement of image-based carcadian rhythms with healthdot data
5-7 days
Discriminative ability of remote, image-based monitoring in the detection of clinical deterioration
Time Frame: 1 year5-7 days
Sensitivity/specificity of image-based data to predict clinical deterioration
1 year5-7 days
Time to detection of clinical deterioration with the image-based monitoring technology vs conventional early warning score (measured via the spot check approach)
Time Frame: 5-7 days
Potential time gain as a result of image-based monitoring in detection of clinical deterioration
5-7 days
Predictive value of each image-based parameter in the detection of postoperative complications
Time Frame: 5-7 days
Added value of each image-based parameters in the detection of clinical deterioration
5-7 days
Effect of clinical deterioration detected with image-based, remote monitoring during hospital admission on long term patient outcomes (mortality, complications)
Time Frame: 2 years
Association of occurence of postoperative complications with long term outcomes
2 years
Invasion of privacy of image-based remote monitoring, experienced by patients and healthcare staff, presented on a likert scale (1 means no invasion of privacy at all and 5 serious invasion of privacy)
Time Frame: 5-7 days
Invasion of privacy will be assessed with a questionnaire with a likert scale (1-5), 1 means no invasion of privacy at all and 5 serious invasion of privacy.
5-7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lukas Dekker, Prof. dr., Catharina Ziekenhuis Eindhoven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2024

Primary Completion (Actual)

February 4, 2025

Study Completion (Actual)

February 4, 2025

Study Registration Dates

First Submitted

September 12, 2023

First Submitted That Met QC Criteria

October 23, 2023

First Posted (Actual)

October 25, 2023

Study Record Updates

Last Update Posted (Actual)

April 11, 2025

Last Update Submitted That Met QC Criteria

April 9, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CZE-2023.28

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vital Signs

Clinical Trials on Image-based vital sign monitoring

Subscribe